Targeting the SR-B1 receptor as a gateway for cancer therapy and tumor imaging

Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently over expressed...

Full description

Bibliographic Details
Main Authors: Linda K Mooberry, Nirupama Avinash Sabnis, Bhavani Nagarajan, Marlyn Panchoo, Andras G Lacko
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00466/full